Unraveling the microenvironmental influences on the normal mammary gland and breast cancer.

The normal mammary gland and invasive breast tumors are both complex 'organs' composed of multiple cell types as well as extracellular matrix in three-dimensional (3D) space. Conventionally, both normal and malignant breast cells are studied in vitro as two-dimensional monolayers of epithelial cells, which results in the loss of structure and tissue function. Many laboratories are now investigating regulation of signaling function in the normal mammary gland using 3D cultures. However, it is also important to assay malignant breast cells ex vivo in a physiologically relevant environment to more closely mimic tumor architecture, signal transduction regulation and tumor behavior in vivo. Here we present the potential of these 3D models for drug testing, target validation and guidance of patient selection for clinical trials. We also argue that in order to get full insight into the biology of the normal and malignant breast, and to create in vivo-like models for therapeutic approaches in humans, we need to continue to create more complex heterotypic models to approach the full context the cells encounter in the human body.

[1]  R. Juliano,et al.  Integrin Signaling , 2005, Cancer and Metastasis Reviews.

[2]  M. Bissell,et al.  Polo-like kinase 1 is involved in invasion through extracellular matrix. , 2007, Cancer research.

[3]  K. Campbell,et al.  A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. , 2002, Cancer research.

[4]  L. Matrisian,et al.  The other side of MMPs: Protective roles in tumor progression , 2007, Cancer and Metastasis Reviews.

[5]  Daniel Birnbaum,et al.  Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. , 2006, Cancer research.

[6]  S. Barsky,et al.  The myoepithelial defense: a host defense against cancer. , 1997, Medical hypotheses.

[7]  W. Muller,et al.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.

[8]  E Ruoslahti,et al.  Integrin signaling. , 1999, Science.

[9]  J. Debnath,et al.  Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner , 2003, The Journal of cell biology.

[10]  G. Vinson,et al.  Integrinβ1-mediated invasion of human breast cancer cells: anex vivo assay for invasiveness , 2003, Breast cancer.

[11]  M. Teixeira,et al.  Cytogenetic clues to breast carcinogenesis , 2002, Genes, chromosomes & cancer.

[12]  R. Weinberg,et al.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.

[13]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[14]  M. Bissell,et al.  Targeting TACE-dependent EGFR ligand shedding in breast cancer. , 2007, The Journal of clinical investigation.

[15]  M. Bissell,et al.  ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini , 2001, Nature Cell Biology.

[16]  Mina J Bissell,et al.  Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. , 2005, Seminars in cancer biology.

[17]  M. Webber,et al.  Laminin-1 and alpha6beta1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells. , 2001, The Prostate.

[18]  O. Fadare,et al.  The Phenotypic Spectrum of Basal-like Breast Cancers: A Critical Appraisal , 2007, Advances in anatomic pathology.

[19]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[20]  S. Swain,et al.  Ductal carcinoma in situ, complexities and challenges. , 2004, Journal of the National Cancer Institute.

[21]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[22]  R. Knuechel,et al.  A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation. , 2001, Experimental cell research.

[23]  L. Liotta,et al.  Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.

[24]  J. Itskovitz‐Eldor,et al.  Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Cunha,et al.  Role of mesenchymal-epithelial interactions in mammary gland development , 2005, Journal of Mammary Gland Biology and Neoplasia.

[27]  V. Weaver,et al.  Tissue structure, nuclear organization, and gene expression in normal and malignant breast. , 1999, Cancer research.

[28]  K. Peck,et al.  Genomic analysis of smooth muscle cells in three‐dimensional collagen matrix , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  K. Bunting ABC Transporters as Phenotypic Markers and Functional Regulators of Stem Cells , 2002, Stem cells.

[30]  Russell Vang,et al.  Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion , 2003, Breast Cancer Research.

[31]  S. Walls,et al.  Biochemical characteristics of hyperplastic rat bile ductular epithelial cells cultured "on top" and "inside" different extracellular matrix substitutes. , 1988, Cancer research.

[32]  Eric Brown,et al.  Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. , 2005, The American journal of pathology.

[33]  P. Alfonsi,et al.  Natural history of breast cancer. , 1992, Lancet.

[34]  C. Larabell,et al.  Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M J Bissell,et al.  Cell shape and hexose transport in normal and virus-transformed cells in culture. , 2010, Journal of supramolecular structure.

[36]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[37]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[38]  L. Tabár,et al.  Natural history of breast cancer , 1992, The Lancet.

[39]  M J Bissell,et al.  Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression : The Role of Extracellular Matrix and Its Degrading Enzymes , 2022 .

[40]  O. Vinante,et al.  Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. , 1997, Journal of the National Cancer Institute.

[41]  G. Page,et al.  Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture , 2004, Breast Cancer Research.

[42]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[43]  O. Petersen,et al.  A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium , 1987, In Vitro Cellular & Developmental Biology.

[44]  Harry Bartelink,et al.  Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas , 2007, Breast Cancer Research.

[45]  M. Bissell,et al.  Cytodifferentiation of mouse mammary epithelial cells cultured on a reconstituted basement membrane reveals striking similarities to development in vivo. , 1991, Journal of cell science.

[46]  B. Gusterson,et al.  Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. , 1982, Cancer research.

[47]  Haiyan I. Li,et al.  Purification and unique properties of mammary epithelial stem cells , 2006, Nature.

[48]  F. Pampaloni,et al.  The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.

[49]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[50]  R. Jain,et al.  Delivery of molecular and cellular medicine to solid tumors. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[51]  Mina J. Bissell The organizing principle: microenvironmental influences in the normal and malignant breast , 2010 .

[52]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[53]  P. Nowell The clonal evolution of tumor cell populations. , 1976, Science.

[54]  Mina J Bissell,et al.  Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. , 2010, Journal of cell science.

[55]  G. Michalopoulos,et al.  Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations. , 1975, Experimental cell research.

[56]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[57]  Genee Y. Lee,et al.  Three-dimensional culture models of normal and malignant breast epithelial cells , 2007, Nature Methods.

[58]  Christopher M. Overall,et al.  Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.

[59]  R. Hansen,et al.  Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. , 2002, Journal of the National Cancer Institute.

[60]  Charles M. Perou,et al.  A Comparison of Gene Expression Signatures from Breast Tumors and Breast Tissue Derived Cell Lines , 2002, Disease markers.

[61]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[62]  J. Folkman Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[63]  Jayanta Debnath,et al.  The Role of Apoptosis in Creating and Maintaining Luminal Space within Normal and Oncogene-Expressing Mammary Acini , 2002, Cell.

[64]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[65]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[66]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[67]  M. Bissell The differentiated state of normal and malignant cells or how to define a "normal" cell in culture. , 1981, International review of cytology.

[68]  J. Baselga,et al.  Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  Lajos Pusztai,et al.  DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: current data and issues on study design. , 2006, Biochimica et biophysica acta.

[70]  David J. Mooney,et al.  Microenvironmental regulation of biomacromolecular therapies , 2007, Nature Reviews Drug Discovery.

[71]  M. Shekhar,et al.  Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. , 2001, Cancer research.

[72]  K. Strebhardt,et al.  Polo-like kinases and oncogenesis , 2005, Oncogene.

[73]  Sophie Lelièvre,et al.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.

[74]  B. O’Malley,et al.  Mammary gland development is mediated by both stromal and epithelial progesterone receptors. , 1997, Molecular endocrinology.

[75]  C. Dabrosin,et al.  Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo. , 2003, Cancer research.

[76]  E. Hay,et al.  SECRETION OF COLLAGEN BY CORNEAL EPITHELIUM , 1973, The Journal of cell biology.

[77]  Alok R Ray,et al.  Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. , 2005, Biomaterials.

[78]  François Vaillant,et al.  Generation of a functional mammary gland from a single stem cell , 2006, Nature.

[79]  Joe W Gray,et al.  Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. , 2006, Cancer research.

[80]  D. Radisky,et al.  Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells , 2004, The Journal of cell biology.

[81]  Genee Y. Lee,et al.  Targeting the tumor microenvironment. , 2007, Frontiers in bioscience : a journal and virtual library.

[82]  C. P. Leblond,et al.  Structure, composition, and assembly of basement membrane. , 1989, The American journal of anatomy.

[83]  Catherine Legrand 1687Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials : Early Breast Cancer Trialists' Collaborative Group (EBCTCG) , 2005 .

[84]  M. Bissell,et al.  The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. , 1995, The Journal of clinical investigation.

[85]  Jeffrey T. Chang,et al.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.

[86]  S. Jaffer,et al.  Chapter 9 – Pathology of Invasive Breast Cancer , 2005 .

[87]  S. Lakhani,et al.  Molecular evolution of breast cancer , 2005, The Journal of pathology.

[88]  J. Pollard Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[89]  M. Bissell,et al.  Of Microenvironments and Mammary Stem Cells , 2007, Stem Cell Reviews.

[90]  Mina J. Bissell,et al.  Evidence for a stem cell hierarchy in the adult human breast , 2007, The Journal of cell biology.

[91]  C. Sotiriou,et al.  Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? , 2007, Nature Reviews Cancer.

[92]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[93]  Genee Y. Lee,et al.  The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.

[94]  Jun Yao,et al.  Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.

[95]  A. Vincent-Salomon,et al.  Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity , 2007, Breast Cancer Research.

[96]  M J Bissell,et al.  The development of a functionally relevant cell culture model of progressive human breast cancer. , 1995, Seminars in cancer biology.

[97]  H. Dressman,et al.  Genomic signatures to guide the use of chemotherapeutics , 2006 .

[98]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[99]  James N Ingle,et al.  American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  R. Knuechel,et al.  Three‐dimensional fibroblast–tumor cell interaction causes downregulation of RACK1 mRNA expression in breast cancer cells in vitro , 2002, International journal of cancer.

[101]  Jonathan Bard,et al.  COLLAGEN SUBSTRATA FOR STUDIES ON CELL BEHAVIOR , 1972, The Journal of cell biology.

[102]  Howard Y. Chang,et al.  Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[103]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[104]  Pingfang Liu,et al.  CEACAM1-4S, a cell–cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[105]  T. Tsukamoto,et al.  Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[106]  M. Bissell,et al.  Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. , 2006, Cancer research.

[107]  Christos Hatzis,et al.  Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[108]  E. Stanley,et al.  Colony-Stimulating Factor-1 Blockade by Antisense Oligonucleotides and Small Interfering RNAs Suppresses Growth of Human Mammary Tumor Xenografts in Mice , 2004, Cancer Research.

[109]  A. Nobel,et al.  The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.

[110]  James D Iglehart,et al.  Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. , 2007, Cancer cell.

[111]  T. Sørlie,et al.  Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome , 2008, The Journal of pathology.

[112]  Ash A. Alizadeh,et al.  Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.

[113]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[114]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[115]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[116]  Frederick Grinnell,et al.  Dendritic fibroblasts in three-dimensional collagen matrices. , 2003, Molecular biology of the cell.

[117]  M. Bissell,et al.  Interaction of mouse mammary epithelial cells with collagen substrata: regulation of casein gene expression and secretion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[118]  H M Jensen,et al.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. , 1975, Journal of the National Cancer Institute.

[119]  P Kelly Marcom,et al.  Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[120]  J. Maher,et al.  Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. , 1987, The Journal of clinical investigation.

[121]  Hui Zhang,et al.  Increased beta1 integrin is associated with decreased survival in invasive breast cancer. , 2007, Cancer research.

[122]  R. Yarden,et al.  Mechanisms of EGF receptor regulation in breast cancer cells , 2004, Breast Cancer Research and Treatment.

[123]  M. Roussel,et al.  Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture , 2004, The Journal of cell biology.

[124]  W. Michael Korn,et al.  Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[125]  M. Bissell,et al.  Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells. , 2007, Cancer research.

[126]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[127]  R. Fässler,et al.  Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation , 2002, The Journal of cell biology.

[128]  I. Mian,et al.  Tissue architecture: the ultimate regulator of breast epithelial function. , 2003, Current opinion in cell biology.

[129]  M. Webber,et al.  Laminin‐1 and α6β1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells , 2001 .

[130]  James A. Clark,et al.  Mammary Gland Development in Adult Mice Requires Epithelial and Stromal Estrogen Receptor α. , 2002, Endocrinology.

[131]  M J Bissell,et al.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.

[132]  M. Bissell,et al.  Glucose metabolite patterns as markers of functional differentiation in freshly isolated and cultured mouse mammary epithelial cells. , 1981, Experimental cell research.

[133]  D. Huntsman,et al.  Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers. , 2006, Current cancer drug targets.

[134]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[135]  James A. Clark,et al.  Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. , 2002, Endocrinology.

[136]  P. Lønning,et al.  Breast cancer prognostication and prediction in the postgenomic era. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[137]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[138]  M J Bissell,et al.  Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[139]  M. Bissell,et al.  Modulation of secreted proteins of mouse mammary epithelial cells by the collagenous substrata , 1984, The Journal of cell biology.

[140]  Peter Devilee,et al.  Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .

[141]  M J Bissell,et al.  How does the extracellular matrix direct gene expression? , 1982, Journal of theoretical biology.

[142]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[143]  J. Waxman,et al.  COX inhibitors and breast cancer , 2006, British Journal of Cancer.

[144]  Z. Shao,et al.  The human myoepithelial cell is a natural tumor suppressor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[145]  Lei Xu,et al.  Tumour biology: Herceptin acts as an anti-angiogenic cocktail , 2002, Nature.

[146]  Mandel Id,et al.  What will the future bring. , 1992 .

[147]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[148]  David C. Lee,et al.  Tumor Necrosis Factor-α Converting Enzyme (TACE) Regulates Epidermal Growth Factor Receptor Ligand Availability* , 2002, The Journal of Biological Chemistry.

[149]  Sandeep Daya,et al.  Culture and differentiation of preadipocytes in two-dimensional and three-dimensional in vitro systems. , 2007, Differentiation; research in biological diversity.

[150]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[151]  R. Jain Delivery of molecular and cellular medicine to solid tumors. , 2001, Advanced drug delivery reviews.

[152]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[153]  P. Gimotty,et al.  Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen‐embedded fibroblasts in organotypic culture , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[154]  M. Shekhar,et al.  Host microenvironment in breast cancer development: Extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast , 2003, Breast Cancer Research.

[155]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[156]  R. Walker,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2005 .

[157]  Mina J. Bissell,et al.  Myoepithelial Cells: Their Origin and Function in Breast Morphogenesis and Neoplasia , 2005, Journal of Mammary Gland Biology and Neoplasia.

[158]  M J Bissell,et al.  Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. , 1989, Development.

[159]  Mina J Bissell,et al.  Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? , 2005, Cancer cell.

[160]  Dan H. Moore,et al.  Increased β1 Integrin Is Associated with Decreased Survival in Invasive Breast Cancer , 2007 .

[161]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[162]  D. Elder,et al.  Human melanoma progression in skin reconstructs : biological significance of bFGF. , 2000, The American journal of pathology.

[163]  J. Pollard,et al.  Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. , 2002, Developmental biology.

[164]  Stefania Forti,et al.  New insights into the role of extracellular matrix during tumor onset and progression , 2002, Journal of cellular physiology.

[165]  F. Huss,et al.  Mammary Epithelial Cell and Adipocyte Co-Culture in a 3-D Matrix: The First Step towards Tissue-Engineered Human Breast Tissue , 2001, Cells Tissues Organs.

[166]  David R. Garrod,et al.  Desmosomal adhesion regulates epithelial morphogenesis and cell positioning , 2001, Nature Cell Biology.

[167]  J. Emerman,et al.  Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes , 1977, In Vitro.

[168]  Rakesh K. Jain,et al.  Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.

[169]  Roy A Jensen,et al.  A human breast cell model of preinvasive to invasive transition. , 2008, Cancer research.

[170]  M. Lacroix,et al.  Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.

[171]  S. Toda,et al.  Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer–stromal cell interactions , 2003, The Journal of pathology.

[172]  P. Kenny TACE: a new target in epidermal growth factor receptor dependent tumors. , 2007, Differentiation; research in biological diversity.

[173]  R. Dickson,et al.  EGF receptor expression, regulation, and function in breast cancer , 2004, Breast Cancer Research and Treatment.

[174]  Ma Dong,et al.  Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer , 2006 .

[175]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[176]  M. Herlyn,et al.  Epidermal Growth Factor Receptor Mediates Increased Cell Proliferation, Migration, and Aggregation in Esophageal Keratinocytes in Vitro and in Vivo * , 2003, The Journal of Biological Chemistry.

[177]  Takashi Suzuki,et al.  Controversies of aromatase localization in human breast cancer—Stromal versus parenchymal cells , 2007, The Journal of Steroid Biochemistry and Molecular Biology.